Today, AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union address:

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today after the Food and Drug Administration (FDA) gave approval for Florida to begin taking the steps needed to import prescription drugs from Canada.

“The court’s decision to allow Medicare drug price negotiations to move forward is welcome news. Pausing Medicare negotiations would have risked billions of dollars in savings for taxpayers...

AARP and AARP Foundation submitted an amicus brief for consideration today in the U.S. District Court for the District of Columbia, urging the court to dismiss Merck & Co.’s lawsuit challenging Medicare’s historic new authority to negotiate lower prescription drug prices.

AARP and AARP Foundation filed an amicus brief today in the U.S. District Court for the Southern District of Ohio, urging the court to dismiss the U.S. Chamber of Commerce’s attempt to block Medicare’s historic new authority to negotiate lower prescription drug prices.